About The Report
We have included an analysis of the gene therapy content presented at the conference including insights such as: abstracts split by type, the primary disease areas of interest split by abstract type, and the key therapies presented based on abstract volume. Additional information from posters, where available, can be found on Beacon.
We hope you found this post-conference report of the gene therapy landscape from the ASGCT 2022 Annual Meeting useful and insightful.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements